Poland· PL-100080869

Curosurf

A natürliche phospholipide product containing poractantum alfa, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 11 of our 19 countries.

ATC R07AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCurosurfATCR07AA02REGISTER NO.PL-100080869PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Natürliche phospholipide is registered in 11 of 19 countries.

Countries holding a registration under ATC R07AA02 (natürliche phospholipide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Natürliche phospholipide · ATC R07AA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Poractantum alfa
Manufacturer
Chiesi Farmaceutici S.p.A.
Country
Poland (PL)
ATC code
R07AA02
ATC class
Natürliche Phospholipide
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990764716
  • gtin
    05909990764723
  • gtin
    05909990764822

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9e4bf256-4f4e-48e0-ad1a-c794613bbe82
GET /v1/drugs/9e4bf256-4f4e-48e0-ad1a-c794613bbe82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do stosowania dotchawiczego i dooskrzelowego",
  "source": "urpl",
  "strength": "80 mg, co odpowiada około 74 mg całej zawartości fosfolipidów i 0,9 mg niskocząsteczkowych hydrofobowych protein.",
  "packaging": "05909990764716 ¦ Lz ¦ 12167\n1 fiol. 3 ml\n05909990764723 ¦ Lz ¦ Skasowane ¦ 21283\n2 fiol. 1,5 ml\n05909990764822 ¦ Lz ¦ 135432\n2 fiol. 1,5 ml",
  "substance": "Poractantum alfa 80 mg",
  "common_name": "Poractantum alfa",
  "pl_product_id": "100080869",
  "pozwolenie_nr": "07647, 07648",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about natürliche phospholipide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.